Cunning Capital Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.73M Hold
5,775
1.39% 23
2025
Q4
$2.7M Sell
5,775
-4,695
-45% -$2.18M 1.25% 25
2025
Q3
$4.46M Hold
10,470
2.07% 14
2025
Q2
$4.01M Hold
10,470
2.09% 13
2025
Q1
$3.62M Sell
10,470
-60
-0.6% -$19.3K 2.31% 12
2024
Q4
$3.16M Hold
10,530
1.89% 16
2024
Q3
$4.28M Hold
10,530
2.24% 9
2024
Q2
$3.38M Hold
10,530
1.89% 10
2024
Q1
$3.51M Hold
10,530
1.94% 9
2023
Q4
$2.85M Hold
10,530
1.78% 12
2023
Q3
$2.59M Buy
+10,530
New +$2.88M 1.7% 10
2023
Q2
Sell
-15,685
Closed -$4.36M 6
2023
Q1
$4.14M Hold
15,685
2.82% 3
2022
Q4
$3.76M Hold
15,685
2.66% 4
2022
Q3
$2.88M Hold
15,685
2.29% 9
2022
Q2
$2.64M Sell
15,685
-11,190
-42% -$2.4M 2.03% 17
2022
Q1
$6.74M Hold
26,875
4.64% 10
2021
Q4
$6.91M Hold
26,875
3.76% 11
2021
Q3
$6.52M Hold
26,875
3.43% 11
2021
Q2
$5.56M Buy
+26,875
New +$5.48M 2.9% 15

Other funds holding HCA

Cunning Capital Partners's HCA Position: Q1 2026 in Review

Cunning Capital Partners held its HCA Healthcare (HCA) position steady in Q1 2026 at 5,775 shares worth $2.73M. The position accounts for 1.39% of the portfolio, ranked #23.

Cunning Capital Partners first reported a position in HCA in Q2 2021 and has held it in 19 quarters since. The position peaked at $6.91M in Q4 2021. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Cunning Capital Partners held 5,775 shares of HCA Healthcare worth $2.73M as of Q1 2026.
  • Cunning Capital Partners left its HCA Healthcare share count unchanged in Q1 2026.
  • HCA Healthcare made up 1.39% of Cunning Capital Partners's portfolio in Q1 2026, its #23 holding.
  • Cunning Capital Partners first reported a position in HCA Healthcare in Q2 2021 and has held it in 19 quarters since.
  • Cunning Capital Partners's HCA Healthcare position peaked at $6.91M in Q4 2021.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Cunning Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.